Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Carbs under the microscope: new study tests how carb type and amount impact metabolism

NCT ID NCT07533513

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how the amount and type of carbohydrates in your diet affect blood sugar, fats, and gut health. Twenty adults with or at risk for metabolic syndrome will eat four different carb diets in a random order. The goal is to understand which carb patterns are best for metabolism.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dietary carbohydrate (varying quantity and glycemic index)
What this could lead to
If successful, this could help design better dietary guidelines for managing or preventing metabolic syndrome.
What could go wrong
This is a small, early-stage study with only 20 participants, so results may not apply broadly. Dietary interventions are hard to control outside the lab.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male and female aged 18 - 65 years; * BMI 20 - 35 kg/m2; * Consent to be randomly assigned to an intervention or control group; * Willingness to eat the food and beverages provided in the study; * Patients with or at high risk of metabolic syndrome, and the diagnostic criteria of metabolic syndrome were based on the Chinese Guidelines for the Prevention and Treatment of diabetes (2024 edition). Exclusion Criteria: * Use of medications that affect blood glucose metabolism; * Familial hyperlipidemia, or use of drugs that affect lipid metabolism; * Long-term or current use of nonsteroidal anti-inflammatory drugs, antibiotics, antihistamines, or immunomodulatory drugs, and unable to stop taking these drugs within 72 h before the start of the study; * Use of hormonal medications such as anticoagulants, anabolic steroids, and hydrocortisone; * Have a history of serious illness, or are in the acute stage of cardiovascular, renal, thyroid, gastrointestinal, hepatobiliary, immunologic, respiratory, neurological, musculoskeletal, psychiatric, infectious, and malignant diseases, and are receiving treatment or use of related drugs; * Self-reported weight gain or loss of more than 7 kg in the 6 months before enrollment; * Vegetarian; * Have food allergies or other problems that may affect food intake; * Unable to consume only the food and beverages provided in the study; * Drink alcohol more than 2 times per day, more than 14 times per week, and unwillingness to stop drinking during the study; * Participate in a weight-loss program; * Unwillingness to maintain weight throughout the study; * Females who have given birth within the past year, are pregnant or plan to become pregnant within 6 months, are breastfeeding; * Intend to participate in other dietary intervention studies and drug use studies in the next 4 months; * Poor venous blood access; * Any other that the physician assessed as unsuitable for the trial conditions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome (METS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sun Yat-sen University

    Shenzhen, Guangdong, 518107, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.